Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy

The aim of this follow-up analysis of the ESPATUE phase 3 trial was to explore the prognostic value of postinduction chemotherapy PET metrics in patients with stage III non–small cell lung cancer who were assigned to receive definitive chemoradiotherapy. Methods: All eligible stage IIIA (cN2) and st...

Descripción completa

Detalles Bibliográficos
Autores principales: Guberina, Maja, Pöttgen, Christoph, Metzenmacher, Martin, Wiesweg, Marcel, Schuler, Martin, Aigner, Clemens, Ploenes, Till, Umutlu, Lale, Gauler, Thomas, Darwiche, Kaid, Stamatis, Georgios, Theegarten, Dirk, Hautzel, Hubertus, Jentzen, Walter, Guberina, Nika, Herrmann, Ken, Eberhardt, Wilfried E.E., Stuschke, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2021
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612197/
https://www.ncbi.nlm.nih.gov/pubmed/34016730
http://dx.doi.org/10.2967/jnumed.120.260646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612197/
https://www.ncbi.nlm.nih.gov/pubmed/34016730
http://dx.doi.org/10.2967/jnumed.120.260646

Ejemplares similares